Jiyeon Si

Jiyeon Si

Auto-generated profile, based on publicly available information

Jiyeon Si

Department of YM-KIST Bio-Health Convergence, Yonsei University Wonju College of Medicine, Wonju-si, Republic of Korea

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2021 in Nature
Verified
Journal Article
Open access
PDF file
JAJavier Aguilera-Lizarraga
Javier Aguilera-Lizarraga
MFMorgane V. Florens
Morgane V. Florens
MVMaria Francesca Viola
Maria Francesca Viola
PJPiyush Jain
Piyush Jain
LDLisse Decraecker
Lisse Decraecker
GBGuy E. Boeckxstaens
Guy E. Boeckxstaens
Up to 20% of people worldwide develop gastrointestinal symptoms following a meal1, leading to decreased quality of life, substantial morbidity and high medical costs. Although the interest of both the scientific and lay communities in this issue has increased markedly in recent years, with the worldwide introduction of gluten-free and other diets, the underlying mechanisms of food-induced abdominal complaints remain largely unknown. Here we show that a bacterial infection and bacterial toxins can trigger an immune response that leads to the production of dietary-antigen-specific IgE antibodies in mice, which are limited to the intestine. Following subsequent oral ingestion of the respective dietary antigen, an IgE- and mast-cell-dependent mechanism induced increased visceral pain. This aberrant pain signalling resulted from histamine receptor H1-mediated sensitization of visceral afferents. Moreover, injection of food antigens (gluten, wheat, soy and milk) into the rectosigmoid mucosa of patients with irritable bowel syndrome induced local oedema and mast cell activation. Our results identify and characterize a peripheral mechanism that underlies food-induced abdominal pain, thereby creating new possibilities for the treatment of irritable bowel syndrome and related abdominal pain disorders.

25 May 2022 in Gut Microbes
Verified
Journal Article
Open access
JSJiyeon Si
Jiyeon Si
HKHyena Kang
Hyena Kang
HYUN JU YOUHYUN JU YOU
HYUN JU YOU
GKGwangPyo Ko
GwangPyo Ko
Despite a short history since its first isolation, Akkermansia muciniphila has been extensively studied in relation to its effects on human metabolism. A recent human intervention study also demonstrated that the bacterium is safe to use for therapeutic purposes. The best-known effects of A. muciniphila in human health and disease relate to its ability to strengthen gut integrity, modulate insulin resistance, and protect the host from metabolic inflammation. A further molecular mechanism, induction of GLP-1 secretion through ICAM-2 receptor, was recently discovered with the identification of a new bacterial protein produced by A. muciniphila. However, other studies have suggested a detrimental role for A. muciniphila in specific host immune settings. Here, we evaluate the molecular, mechanistic effects of A. muciniphila in host health and suggest some of the missing links to be connected before the organism should be considered as a next-generation biotherapeutic agent.

14 October 2022 in Nature Aging
Verified
Journal Article
Open access
PDF file
JSJiyeon Si
Jiyeon Si
JVJorge F. Vázquez-Castellanos
Jorge F. Vázquez-Castellanos
AGAnn C. Gregory
Ann C. Gregory
LDLindsey Decommer
Lindsey Decommer
LRLeen Rymenans
Leen Rymenans
JRJeroen Raes
Jeroen Raes
Extensive scientific and clinical microbiome studies have explored contemporary variation and dynamics of the gut microbiome in human health and disease1–3, yet the role of long-term life history effects has been underinvestigated. Here, we analyzed the current, quantitative microbiome composition in the older adult Bruneck Study cohort (Italians, Bruneck,n = 304 (male, 154; female, 150); age 65–98 years) with extensive clinical, demographic, lifestyle and nutritional data collected over the past 26 years4. Multivariate analysis of historical variables indicated that medication history, historical physical activity, past dietary habits and specific past laboratory blood parameters explain a significant fraction of current quantitative microbiome variation in older adults, enlarging the explanatory power of contemporary covariates by 33.4%. Prediction of current enterotype by a combination of past and contemporary host variables revealed good levels of predictability (area under the curve (AUC), 0.78–0.83), withPrevotellaand dysbioticBacteroides2 being the best predicted enterotypes. These findings demonstrate long-term life history effects on the microbiota and provide insights into lifestyle variables and their role in maintaining a healthy gut microbiota in later life.

23 March 2026 in Gut
Verified
Journal Article
Open access
JVJorge F Vázquez-Castellanos
Jorge F Vázquez-Castellanos
SYSang Jun Yoon
Sang Jun Yoon
SWSung-Min Won
Sung-Min Won
JRJeroen Raes
Jeroen Raes
HKHak Cheol Kwon
Hak Cheol Kwon
KSKi Tae Suk
Ki Tae Suk
Background: The gut-liver axis plays a critical role in liver disease progression; however, how gut microbial ecology and function vary across disease stages remains unclear. Objective: To define stage-specific microbial and functional signatures and evaluate their diagnostic potential. Design: We analysed faecal samples from 1168 individuals spanning healthy controls, fatty liver, hepatitis, cirrhosis and hepatocellular carcinoma by 16S rRNA sequencing, with a subset (n=141) profiled by shotgun metagenomics. To increase statistical power and enable external validation, 2376 publicly available metagenomic datasets, including 734 liver-related, were integrated. Machine learning-based multicohort analysis was used to identify microbial biomarkers, assess risk factors and classify disease stages. Results: Microbial diversity declined and a low-richness enterotype expanded with disease severity. Machine learning revealed a discordance in hepatitis, which lacked taxonomic markers but was defined by a conserved functional signature of biosynthetic upregulation. In contrast, advanced stages featured consistent markers like Ligilactobacillus and Veillonella , with strain-level evidence confirming oral-gut transmission. Functional profiling delineated a metabolic continuum from anabolic precursor synthesis in hepatitis to virulence factor production in cirrhosis and putrefactive metabolism in carcinoma. Comparative analysis confirmed that these signatures were distinct from those in non-liver metabolic and oncologic disorders. Importantly, the expansion of oral-derived Veillonella spp and the low-richness enterotype were significantly associated with increased mortality. Conclusion: This large-scale study delineates stage-dependent ecological and functional remodelling of the gut microbiome across liver diseases. These findings highlight the potential of microbiome-based markers for non-invasive diagnosis and prognostic risk stratification in liver diseases.

25 January 2021 in Research Square
Verified
Preprint
Open access
PDF file
JRJeroen Raes
Jeroen Raes
JSJiyeon Si
Jiyeon Si
AGAnn Gregory
Ann Gregory
JVJorge Vázquez-Castellanos
Jorge Vázquez-Castellanos
LDLindsey Decommer
Lindsey Decommer
HTHerbert Tilg
Herbert Tilg
Extensive scientific and clinical microbiome studies have explored contemporary variation and dynamics of the gut microbiome in human health and disease1–4, yet the role of long-term life-history effects is underinvestigated. Here, we analyzed the current microbiome composition in the elderly Bruneck Study cohort (n = 304; age 65–98) with extensive clinical, demographic, lifestyle, and nutritional data collected over the past 26 years. Combined analysis with the Flemish Gut Flora Project cohort (FGFP; n = 2,215; age 18–85) showed community richness increasing during aging linked to increased observation of low-abundance bacteria. Multivariate analysis of historical variables indicated that medication history, historical physical activity, past dietary habits, and specific past laboratory parameters explain a significant fraction of current elderly quantitative microbiome variation, enlarging the explanatory power of contemporary covariates by 33.4%. Prediction of current enterotype by past host variables revealed good levels of predictability (AUC > 0.7) for the Prevotella and dysbiotic Bacteroides 2 enterotypes with information from up to 15 years past. These findings demonstrate long-term life history effects on the microbiota and provide first insights into lifestyle variables and their role in maintaining a healthy gut microbiota in later life.